———-Professor Robert Gallo, Globally Acclaimed Co-Discoverer of HIV expected to grace the occasion among other dignitaries
The Institute of Human Virology Nigeria (IHVN) has announced it will officially launch its state-of-the-art multi-campus of excellence in public healthcare, treatment training, and research to bring quality health services within the reach of millions of Nigerians.
The IHVN Campus, located on Plot 62, Emeritus Umaru Shehu Avenue, Cadastral Zone, COO, Abuja, is a combination of leasable office buildings, clinical laboratories for diagnosis, research, and training, functional clinic spaces for patient care and clinical trials, bio-specimen repositories for storage and management of bio-specimens, multi-media lecture auditoriums and meeting rooms and offices.
The event, which will take place on June 6, will be preceded by a scientific seminar on addressing local health challenges through quality research and partnership. The seminar will bring together key scientists and public-private stakeholders in the health sector with Professor Robert Gallo, Director, Institute of Human Virology, Baltimore USA; Professor Alash’le Abimiku, Executive Director, International Research Center of Excellence (IRCE), and Dr. Ifedayo Morayo Adetifa, Director General of Nigerian Center for Disease Control (NCDC) as the main speakers.
As an internationally recognized local and nonprofit organization, IHVN is structured to develop and maintain linkages with other local and international organizations, in collaborative ways that support the Government of Nigeria’s health sector strategic plans. IHVN focuses on the prevention, treatment, and management of diseases such as HIV/AIDS, TB, malaria, COVID-19, Cancer, and other infectious and non-infectious diseases.
Speaking about the development, the Chief Executive Officer of the Institute of Human Virology of Nigeria, Dr. Patrick Dakum, says “The commissioning of the IHVN Campus demonstrates the Institute’s commitment as a leader in providing health service implementation, capacity building, research and ensuring equitable access to quality healthcare services through innovative and evidence-based strategies.” Dr. Dakum also says that with its two centers now on campus: the Program Implementation Center (PIC) and the International Research Center of Excellence, the Institute will continue to develop training and expertise for the sustainability of HIV/AIDS, TB, Malaria, and Cancer programs.
The commissioning of the IHVN Campus is expected to revolutionize the fight against emerging infectious and non-infectious diseases in Nigeria and the African Continent.
The Institute of Human Virology Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine. It was incorporated in March 2004 as a local non-governmental organization with a Board of Directors. IHVN has provided care and treatment to over 570,000 individuals living with HIV in Nigeria since 2004. It has trained more than 49,000 healthcare providers for quality care for peope living with HIV, TB, malaria, cancer and other diseases. The Institute has supported over 100 laboratories in Nigeria to implement a Quality Management System. Two of the supported laboratories have achieved international accreditation and technical assistance is being provided to Nigerian Center for Disease control (NCDC) yellow fever laboratory network to achieve international accreditation. For more information, visit www.ihvnigeria.org or contact the Communications Department of IHVN on Plot 62, Emeritus Umaru Shehu Avenue, Cadastral Zone COO, after Baze University, Abuja, FCT. Click: About Dr. Robert C. Gallo | University of Maryland School of Medicine (ihv.org) & Abimiku, Alash’le | University of Maryland School of Medicine (umaryland.edu)